Tempest Therapeutics, Inc. Share Price
TPSTTempest Therapeutics, Inc. Stock Performance
Open $2.42 | Prev. Close $2.64 | Circuit Range N/A |
Day Range $2.42 - $2.67 | Year Range $2.42 - $13.13 | Volume 2,340 |
Average Traded $2.60 |
Tempest Therapeutics, Inc. Share Price Chart
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Tempest Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
14-Jan-26 | $2.56 | $2.56 | -12.48% |
09-Jan-26 | $2.89 | $2.92 | -0.17% |
08-Jan-26 | $2.86 | $2.93 | +3.53% |
07-Jan-26 | $2.83 | $2.83 | +1.07% |
06-Jan-26 | $2.80 | $2.80 | -4.11% |
05-Jan-26 | $3.02 | $2.92 | -0.68% |
02-Jan-26 | $2.87 | $2.94 | +2.44% |
FAQs on Tempest Therapeutics, Inc. Share Price
Can I buy Tempest Therapeutics, Inc. shares in India?
What is the share price of Tempest Therapeutics, Inc.?
What is the 5 year returns of Tempest Therapeutics, Inc.?
What are the high & low stock price of Tempest Therapeutics, Inc. today?
What is the 52-week high and low of Tempest Therapeutics, Inc. stock?